151 related articles for article (PubMed ID: 37082491)
1. Clinical Profile and Quality of Life of Patients With Post-pulmonary Tuberculosis Sequelae Presenting to a Tertiary Care Hospital.
Thoker ZA; Madan K; Mittal S; Tiwari P; Shah TH; Mohan A; Hadda V; Guleria R
Cureus; 2023 Mar; 15(3):e36354. PubMed ID: 37082491
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Chronic Pulmonary Aspergillosis Co-infection on the Health-Related Quality of Life of Patients with Pulmonary Tuberculosis in Uganda.
Namusobya M; Bongomin F; Mukisa J; Batte C; Olwit WK; Rhein J; Sekaggya-Wiltshire C; Prasad S
Mycopathologia; 2023 Oct; 188(5):713-720. PubMed ID: 37195546
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Chronic Pulmonary Aspergillosis Co-infection on the Health-Related Quality of Life of Patients with Pulmonary Tuberculosis in Uganda.
Namusobya M; Bongomin F; Mukisa J; Batte C; Olwit WK; Rhein J; Sekaggya-Wiltshire C; Prasad S
Res Sq; 2023 Jan; ():. PubMed ID: 36711486
[TBL] [Abstract][Full Text] [Related]
4. Integrated disease management interventions for patients with chronic obstructive pulmonary disease.
Poot CC; Meijer E; Kruis AL; Smidt N; Chavannes NH; Honkoop PJ
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD009437. PubMed ID: 34495549
[TBL] [Abstract][Full Text] [Related]
5. Integrated disease management interventions for patients with chronic obstructive pulmonary disease.
Kruis AL; Smidt N; Assendelft WJ; Gussekloo J; Boland MR; Rutten-van Mölken M; Chavannes NH
Cochrane Database Syst Rev; 2013 Oct; (10):CD009437. PubMed ID: 24108523
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary rehabilitation for chronic obstructive pulmonary disease.
McCarthy B; Casey D; Devane D; Murphy K; Murphy E; Lacasse Y
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD003793. PubMed ID: 25705944
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena.
Ralph AP; Kenangalem E; Waramori G; Pontororing GJ; Sandjaja ; Tjitra E; Maguire GP; Kelly PM; Anstey NM
PLoS One; 2013; 8(11):e80302. PubMed ID: 24312209
[TBL] [Abstract][Full Text] [Related]
9. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
[TBL] [Abstract][Full Text] [Related]
10. Risk factors associated with development of pulmonary impairment after tuberculosis.
Gandhi K; Gupta S; Singla R
Indian J Tuberc; 2016 Jan; 63(1):34-8. PubMed ID: 27235942
[TBL] [Abstract][Full Text] [Related]
11. Validity of the St George's respiratory questionnaire at acute exacerbation of chronic bronchitis: comparison with the Nottingham health profile.
Doll H; Duprat-Lomon I; Ammerman E; Sagnier PP
Qual Life Res; 2003 Mar; 12(2):117-32. PubMed ID: 12639059
[TBL] [Abstract][Full Text] [Related]
12. Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry.
Wuyts WA; Dahlqvist C; Slabbynck H; Schlesser M; Gusbin N; Compere C; Maddens S; Rizzo S; Kirchgaessler KU; Bartley K; Bondue B
Pulm Ther; 2022 Jun; 8(2):181-194. PubMed ID: 35429319
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of a linear analog scale questionnaire to measure health-related quality of life in elderly patients with chronic obstructive pulmonary disease.
Katsura H; Yamada K; Kida K
J Am Geriatr Soc; 2003 Aug; 51(8):1131-5. PubMed ID: 12890078
[TBL] [Abstract][Full Text] [Related]
14. Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity.
Lee H; Jhun BW; Cho J; Yoo KH; Lee JH; Kim DK; Lee JD; Jung KS; Lee JY; Park HY
Int J Chron Obstruct Pulmon Dis; 2017; 12():3301-3310. PubMed ID: 29180860
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Imaging Features of Adults with Recurrent Pulmonary Tuberculosis - A Prospective Case-Controlled Study.
Nagu TJ; Mboka MA; Nkrumbih ZF; Shayo G; Mizinduko MM; Komba EV; Maeurer M; Zumla A; Mugusi F
Int J Infect Dis; 2021 Dec; 113 Suppl 1():S33-S39. PubMed ID: 33716197
[TBL] [Abstract][Full Text] [Related]
16. Self-management interventions for people with chronic obstructive pulmonary disease.
Schrijver J; Lenferink A; Brusse-Keizer M; Zwerink M; van der Valk PD; van der Palen J; Effing TW
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD002990. PubMed ID: 35001366
[TBL] [Abstract][Full Text] [Related]
17. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
[TBL] [Abstract][Full Text] [Related]
18. Airway clearance techniques for bronchiectasis.
Lee AL; Burge AT; Holland AE
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008351. PubMed ID: 26591003
[TBL] [Abstract][Full Text] [Related]
19. Duration of treatment in pulmonary tuberculosis: are international guidelines on the management of tuberculosis missing something?
Atif M; Sulaiman SA; Shafie AA; Babar ZU
Public Health; 2015 Jun; 129(6):777-82. PubMed ID: 25999175
[TBL] [Abstract][Full Text] [Related]
20. Risk factors influencing rebleeding after bronchial artery embolization on the management of hemoptysis associated with pulmonary tuberculosis.
Hwang HG; Lee HS; Choi JS; Seo KH; Kim YH; Na JO
Tuberc Respir Dis (Seoul); 2013 Mar; 74(3):111-9. PubMed ID: 23579345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
